1-4 of 4
Rasmus Rojkjaer
Close
Sort by
Journal Articles

Recombinant Factor VIIa Combined with Plasma Factor XIII Stabilize Clot Formation and Increase Clot Stability in Whole Blood from Patients with Severe Hemophilia A.

Benny Sorensen, MD, PhD, Rasmus Rojkjaer, Ph.D., Jorgen Ingerslev, MD, DMSC
Journal: Blood
Blood (2006) 108 (11): 1039.
https://doi.org/10.1182/blood.V108.11.1039.1039
Published: 2006
Journal Articles

Tissue Factor-Dependent Cellular Responses of Factor VII/VIIa in the Absence and Presence of Factor X.

Lars C. Petersen, PhD, DSc, Tatjana Albrektsen, PhD, Gertrud M. Hjortø, PhD, Marianne Kjalke, PhD, Rasmus Rojkjaer, PhD, Søren E. Bjørn, PhD, Brit B. Sørensen, PhD
Journal: Blood
Blood (2005) 106 (11): 1940.
https://doi.org/10.1182/blood.V106.11.1940.1940
Published: 2005
Journal Articles

Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A

Mikael Tranholm, Kim Kristensen, Annemarie T. Kristensen, Charles Pyke, Rasmus Røjkjær, Egon Persson
Journal: Blood
Blood (2003) 102 (10): 3615–3620.
https://doi.org/10.1182/blood-2003-05-1369
Published: 2003
Journal Articles

High Molecular Weight Kininogen Regulates Prekallikrein Assembly and Activation on Endothelial Cells: A Novel Mechanism for Contact Activation

Guacyara Motta, Rasmus Rojkjaer, Ahmed A.K. Hasan, Douglas B. Cines, Alvin H. Schmaier
Journal: Blood
Blood (1998) 91 (2): 516–528.
https://doi.org/10.1182/blood.V91.2.516
Published: 1998